Does Cabometyx (cabozantinib) cure cancer?
Medically reviewed by N. France, BPharm. Last updated on Feb 28, 2021.
Official Answer
by Drugs.comCabometyx (cabozantinib) does not cure cancer. It is a tyrosine kinase inhibitor that is approved to treat:
- Advanced renal cell carcinoma (kidney cancer)
- Advanced renal cell carcinoma, as a first-line treatment in combination with nivolumab (Opdivo)
- Hepatocellular carcinoma (liver cancer) in people who have previously been treated with sorafenib (Nexavar)
Cabometyx is used to delay the progression of cancer and increase the length of time a person with cancer survives for. How effective Cabometyx is at doing this depends on the type of cancer a person has and how advanced it is.
Patients on Cabometyx typically keep taking it until their cancer progresses or they have to stop because of side effects or adverse reactions.
References
- Food and Drug Administration (FDA). Cabometyx. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208692s010lbl.pdf. [Accessed March 1, 2021].
Related Medical Questions
- Is Cabometyx a chemotherapy drug?
- How does Cabometyx work?
- How long do you take Cabometyx for?
- What is the success rate of Cabometyx (cabozantinib)?
- What is the difference between Cabometyx and Cometriq?
Drug Information
Related Support Groups
- Cabometyx (6 questions, 7 members)
- Cabozantinib (4 questions, 4 members)
- Cancer (101 questions, 601 members)
- Renal Cell Carcinoma (11 questions, 93 members)
- Hepatocellular Carcinoma (7 questions, 21 members)